Fig. 1: Comparison of the number of somatic alterations and medium maximum MAF in MSI-H versus non-MSI-H samples. | npj Breast Cancer

Fig. 1: Comparison of the number of somatic alterations and medium maximum MAF in MSI-H versus non-MSI-H samples.

From: Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer

Fig. 1: Comparison of the number of somatic alterations and medium maximum MAF in MSI-H versus non-MSI-H samples.

a Distribution of the number of somatic alterations detected per sample, including synonymous variants and variants of uncertain significance, excluding amplifications, in MSI-H versus non-MSI-H samples. The number of somatic alterations in individual samples is represented by colored dots with median value and interquartile range outlined in black. b Median maximum MAF in MSI-H versus non-MSI-H samples (Mann–Whitney U-test p < 0.0001).

Back to article page